Mail

UK markets closed

FTSE 100
8,433.76
+52.41(+0.63%)
FTSE 250
20,645.38
+114.08(+0.56%)
AIM
789.87
+6.17(+0.79%)
GBP/EUR
1.1622
+0.0011(+0.09%)
GBP/USD
1.2525
+0.0001(+0.01%)
Bitcoin GBP
48,453.43
-1,510.16(-3.02%)

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

Aldeyra Therapeutics, Inc. (ALDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

3.7700

-0.1700

(-4.31%)

At close: 04:00PM EDT

3.9150

+0.14

(+3.85%)

After hours:

05:36PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	234.69M
Enterprise value	117.31M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	2.07
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	1.44
52-week change ³	-61.22%
S&P500 52-week change ³	26.43%
52-week high ³	11.9700
52-week low ³	1.4200
50-day moving average ³	3.7380
200-day moving average ³	4.2710

Share statistics

Avg vol (3-month) ³	575.19k
Avg vol (10-day) ³	327.14k
Shares outstanding ⁵	59.41M
Implied shares outstanding ⁶	59.41M
Float ⁸	43.16M
% held by insiders ¹	2.49%
% held by institutions ¹	61.02%
Shares short (15 Apr 2024) ⁴	2.36M
Short ratio (15 Apr 2024) ⁴	3.08
Short % of float (15 Apr 2024) ⁴	4.79%
Short % of shares outstanding (15 Apr 2024) ⁴	3.97%
Shares short (prior month 15 Mar 2024) ⁴	1.83M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-14.29%
Return on equity (ttm)	-23.94%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-35.13M
Net income avi to common (ttm)	-30.01M
Diluted EPS (ttm)	-0.5100
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	83.04M
Total cash per share (mrq)	1.4
Total debt (mrq)	15.66M
Total debt/equity (mrq)	13.81%
Current ratio (mrq)	6.50
Book value per share (mrq)	1.91

Cash flow statement

Operating cash flow (ttm)	-30.85M
Levered free cash flow (ttm)	-83.51M